Comparison of Topoisomerase-IIα Gene Status between Primary Breast Cancer and Corresponding Distant Metastatic Sites
- 1 February 2003
- journal article
- research article
- Published by Springer Nature in Breast Cancer Research and Treatment
- Vol. 77 (3) , 199-204
- https://doi.org/10.1023/a:1021874224490
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sitesAnnals of Oncology, 2002
- Evaluation of HER2, p53, bcl-2, topoisomerase II-α, heat shock proteins 27 and 70 in primary breast cancer and metastatic ipsilateral axillary lymph nodesAnnals of Oncology, 2001
- c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissuesJournal of Surgical Oncology, 2000
- Differential expression of DNA topoisomerase II α and -β in P-gp and MRP-negative VM26, mAMSA and mitoxantrone-resistant sublines of the human SCLC cell line GLC4British Journal of Cancer, 1996
- Selection of a subpopulation with fewer DNA topoisomerase II alpha gene copies in a doxorubicin-resistant cell line panelBritish Journal of Cancer, 1996
- Ectopic expression of inactive forms of yeast DNA topoisomerase II confers resistance to the anti-tumour drug, etoposideBritish Journal of Cancer, 1996
- Breast cancer heterogeneity: Evaluation of clonality in primary and metastatic lesionsHuman Pathology, 1995
- Stability of HER-2/neu Expression Over Time and at Multiple Metastatic SitesJNCI Journal of the National Cancer Institute, 1993
- An immunohistochemical evaluation of c-erbB-2 expression in human breast carcinomaBritish Journal of Cancer, 1988
- Human Breast Cancer: Correlation of Relapse and Survival with Amplification of the HER-2/ neu OncogeneScience, 1987